Erez Aminov
CEO and Director at MIRA Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: MIRA Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
MIRA Pharmaceuticals Inc. September 11, 202698.9%
-
MIRA Pharmaceuticals Inc. September 11, 202598.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 22, 2026 | Telomir Pharmaceuticals Inc. | Other | +7,319,710 | $1.37 | $10,028,003 |
| Oct 16, 2025 | MIRA Pharmaceuticals Inc. | Option exercise | +234,595 | $1.16 | $272,130 |
| Oct 16, 2025 | MIRA Pharmaceuticals Inc. | Option exercise | +379,000 | $0.84 | $318,360 |
| Oct 16, 2025 | MIRA Pharmaceuticals Inc. | Open-market sale | −613,595 | $2.11 | $1,294,685 |
| Oct 1, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +2,685,456 | — | — |
| Aug 29, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +62,500 | $1.37 | $85,625 |
| Mar 26, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +62,500 | $1.45 | $90,625 |
| Mar 26, 2025 | MIRA Pharmaceuticals Inc. | Grant or award | +62,500 | $1.45 | $90,625 |
| Nov 20, 2024 | MIRA Pharmaceuticals Inc. | Open-market sale | −44,590 | $1.27 | $56,629 |
| Nov 19, 2024 | MIRA Pharmaceuticals Inc. | Open-market sale | −55,410 | $1.39 | $77,020 |
| Aug 19, 2024 | Telomir Pharmaceuticals Inc. | Open-market sale | −200 | $6.01 | $1,202 |
| Aug 19, 2024 | Telomir Pharmaceuticals Inc. | Open-market sale | −200 | $6.20 | $1,240 |
| May 21, 2024 | MIRA Pharmaceuticals Inc. | Open-market purchase | +2,000 | $1.00 | $2,000 |
| May 21, 2024 | MIRA Pharmaceuticals Inc. | Open-market purchase | +1,000 | $1.03 | $1,030 |
| May 21, 2024 | MIRA Pharmaceuticals Inc. | Open-market purchase | +500 | $1.02 | $510 |
Questions about Erez Aminov
What boards is Erez Aminov on?
Erez Aminov sits on the boards of MIRA Pharmaceuticals Inc. and Telomir Pharmaceuticals Inc.
What company is Erez Aminov the CEO of?
Erez Aminov has been CEO and Director of MIRA Pharmaceuticals Inc. since August 2023 and Erez Aminov has been CEO & Chairman of Telomir Pharmaceuticals Inc. since August 2024.
How long has Erez Aminov served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.